1. Home
  2. ATYR vs NREF Comparison

ATYR vs NREF Comparison

Compare ATYR & NREF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo aTyr Pharma Inc.

ATYR

aTyr Pharma Inc.

HOLD

Current Price

$0.85

Market Cap

69.2M

Sector

Health Care

ML Signal

HOLD

Logo NexPoint Real Estate Finance Inc.

NREF

NexPoint Real Estate Finance Inc.

HOLD

Current Price

$13.15

Market Cap

263.3M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATYR
NREF
Founded
2005
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
69.2M
263.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ATYR
NREF
Price
$0.85
$13.15
Analyst Decision
Hold
Hold
Analyst Count
8
2
Target Price
$4.20
$14.50
AVG Volume (30 Days)
1.4M
43.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
14.10%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$9,628.95
$24.65
Revenue Next Year
$156.94
N/A
P/E Ratio
N/A
$4.78
Revenue Growth
N/A
N/A
52 Week Low
$0.64
$12.14
52 Week High
$7.29
$16.80

Technical Indicators

Market Signals
Indicator
ATYR
NREF
Relative Strength Index (RSI) 43.50 28.00
Support Level $0.82 $12.36
Resistance Level $0.85 $15.25
Average True Range (ATR) 0.07 0.42
MACD -0.02 -0.12
Stochastic Oscillator 7.78 5.45

Price Performance

Historical Comparison
ATYR
NREF

About ATYR aTyr Pharma Inc.

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

About NREF NexPoint Real Estate Finance Inc.

NexPoint Real Estate Finance Inc is a real estate investment trust. The company provides structured financing solutions by investing in mid-sized multifamily, storage and select-service, and extended-stay hospitality properties. Its investment objective is to generate attractive, risk-adjusted returns for stockholders over the long term. The Company is focused on originating, structuring and investing in first-lien mortgage loans, mezzanine loans, preferred equity, convertible notes, multifamily properties, and common equity investments, as well as multi-family and single-family rental ("SFR") commercial mortgage-backed securities securitizations ("CMBS securitizations"), multifamily structured credit risk notes ("MSCR Notes") and mortgage-backed securities.

Share on Social Networks: